Navigation Links
'Freezing' Secondary Breast Cancer Tumors Shows Promise
Date:3/26/2012

MONDAY, March 26 (HealthDay News) -- In a small and preliminary study, researchers report that they successfully froze secondary tumors in patients with incurable breast cancer.

The findings raise the prospect of a potential new treatment for metastatic tumors in individual patients, although the research is in the very early stages.

"This therapy provides a minimal rate of cancer recurrence and no major complications," study co-author Dr. Peter Littrup, director of imaging core and radiology research at the Karmanos Cancer Institute in Detroit, said in a news release from the Society of Interventional Radiology.

The study is scheduled to be presented Wednesday at the society's annual meeting in San Francisco. Research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed medical journal.

"This is a preliminary study, and at this point we're hoping that the evidence could be a stepping stone for a bigger study to look at more patients," Littrup said. "If we can get more data that supports percutaneous cryoablation for metastatic breast cancer, it could be a huge finding."

In percutaneous cryoablation, tiny probes insert pressurized argon gas into tumors and kill them by turning them into balls of ice.

The eight patients in the study had stage 4 metastatic breast cancer, meaning their tumors had spread widely from the breast. The tumors frequently appear in organs such as the liver, lungs, bones and kidneys.

In stage 4, the disease is considered incurable.

"At this point, treatments are considered palliative -- with the intent to keep metastases at bay while hopefully providing individuals more time and improved quality of life, rather than a complete cure," Littrup said.

"Cryoablation as a targeted therapy is beneficial because it can significantly reduce discomfort and incidence of disease," Littrup said. "It's a much better option, we think, than surgery -- especially since many metastatic patients are not candidates for surgery -- and it may potentially lead to longer survival."

The eight patients in the study lived for an average of 46 months, and two survived for at least five years.

Dr. Hannah Linden, an oncology specialist and assistant professor at the University of Washington School of Medicine in Seattle, said it's too early to know whether the treatment works since it hasn't been compared to other therapies.

"Many patients with metastatic breast cancer live a long time with gentle treatments, yet other patients who have relatively resistant tumors do poorly," she said. "While the idea of freezing a tumor to prevent it from growing is feasible and exciting, it is not proven that such an approach actually 'cures' patients or provides long-term benefit."

Although similar treatments target secondary tumors, she added, they "do not address the systemic problem of metastatic cancer. So, while it seems good to 'kill' the metastasis, the cancer is still lurking."

Breast cancer is the most common cancer among women, killing nearly 370,000 people worldwide each year. Approximately 10,000 to 15,000 new cases of stage 4 breast cancer occur in the United States each year, Littrup noted.

More information

For more about breast cancer, visit the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCES: Society of Interventional Radiology, news release, March 26, 2012; Hannah Linden, M.D., assistant professor, University of Washington School of Medicine, Seattle


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Wayne State proves targeted tumor freezing therapy increases ovarian cancer survival
2. Freezing Wrinkles a Possible Alternative to Botox
3. For Common Warts, Freezing Therapy Works Best: Study
4. Studies of womens attitudes to social egg freezing find reasons differ with age
5. Freezing Tumors Shows Promise Against Prostate, Breast Cancer
6. Freezing, Medicating Away a Dangerous Irregular Heart Rhythm
7. Freezing Technique May Stop Breast Cancer
8. Freezing breast tumors helps stop cancer’s spread in mice, U-M study finds
9. Malnutrition as a secondary symptom
10. Researchers focus on secondary stroke prevention after study reveals room for improvement
11. Urgent steps needed to tackle inadequate support for women with secondary breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Freezing' Secondary Breast Cancer Tumors Shows Promise
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Assili, announce that they are now offering treatments for sleep apnea and TMJ ... dental offices. Sleep apnea , specifically the obstructive type, is increasingly being ...
(Date:3/24/2017)... ... 2017 , ... The law firm of Enea, Scanlan & Sirignano, LLP, ... resident Lauren C. Enea has joined the firm as an associate attorney. Ms. Enea, ... in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. Samantha ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is to ... Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. Food ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate ... during what is often a very difficult and challenging time.” , A Certified ...
(Date:3/24/2017)... ... 2017 , ... “End Time GPS”: a dauntless and enlightened study of ... GPS” is the creation of published author, Wesley Gerboth, a World War II veteran, ... space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon him ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the addition of the ... offering. ... is very strong with a total of 97 drug candidates. Pharma giant ... are involved in the development of the IPF therapeutics. The IPF pipeline ... stage, 15 are in Phase II stage, 12 are in Phase I ...
(Date:3/24/2017)... Global Ampoules Market report provides ... applications and industry chain structure. The Ampoules market analysis ... competitive landscape analysis, and major regions, development status. ... ... providing 10 company profiles and 183 tables and figures ...
(Date:3/24/2017)... March 24, 2017  GenomeDx Biosciences today announced that ... and Decipher® Prostate Cancer Classifier tests will be presented ... Urology (EAU) Congress held March 24 to 28, 2017 ... EAU Congress is Europe,s largest ... in the urological field. The abstract titled ...
Breaking Medicine Technology: